STAR Pharmaceutical Limited announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was CNY 89.221 million compared to CNY 37.137 million a year ago. Operating loss was CNY 17.973 million compared to CNY 996,000 a year ago. Net loss was CNY 15.959 million compared to net income of CNY 3.122 million a year ago. Basic loss per share was CNY 0.3479 compared to basic earnings per share of CNY 0.0672 a year ago. For the half year, sales was CNY 212.448 million compared to CNY 104.714 million a year ago. Operating loss was CNY 7.652 million compared to operating Income of CNY 8.356 million a year ago. Net loss was CNY 9.010 million compared to net income of CNY 9.995 million a year ago. Basic loss per share was CNY 0.1957 compared to basic earnings per share of CNY 0.215 a year ago.